RXDX
Principal Financial Group’s Prometheus Biosciences, Inc. Common Stock RXDX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-167,475
| Closed | -$18M | – | 2543 |
|
|
2023
Q1 | $18M | Buy |
167,475
+157,166
| +1,525% | +$16.9M | 0.01% | 912 |
|
|
2022
Q4 | $1.13M | Buy |
10,309
+1,404
| +16% | +$154K | ﹤0.01% | 1844 |
|
|
2022
Q3 | $526K | Sell |
8,905
-5
| -0.1% | -$295 | ﹤0.01% | 1948 |
|
|
2022
Q2 | $251K | Buy |
+8,910
| New | +$251K | ﹤0.01% | 2232 |
|